Citation Impact
Citing Papers
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Fibronectin EDA Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor Signaling
2014
Fibroblasts in fibrosis: novel roles and mediators
2014
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Regulatory mechanisms of microRNA expression
2016
The effects of Eculizumab on the pathology of malignant atrophic papulosis
2013
Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease
2020
Fibrosing connective tissue disorders of the skin: Molecular similarities and distinctions
2013
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
2019
National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis
2014
Hallmarks of aging: An expanding universe
2023 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Genetic factors and systemic sclerosis
2016
Systemic sclerosis
2017 Standout
Inflammation and fibrosis
2017
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
2020 Standout
Regulatory B cells in inflammatory diseases and tumor
2018
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Wnt signaling pathway in aging-related tissue fibrosis and therapies
2020
The natural history of progressive fibrosing interstitial lung diseases
2019
Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
2019 Standout
Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study
2016
Genetics of systemic sclerosis
2015
Remodelling the extracellular matrix in development and disease
2014 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Extracorporeal photopheresis for the treatment of autoimmune diseases
2015
Photopheresis: Advances and Use in Systemic Sclerosis
2017
Metabolic orchestration of the wound healing response
2021
Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts
2015
Environmental risk factors of systemic sclerosis
2015
Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells
2015
Emerging cellular and molecular targets in fibrosis
2014
Systemic sclerosis
2015
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
MicroRNA
2017 Standout
MicroRNA as Therapeutic Targets for Chronic Wound Healing
2017
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
2019
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
2019
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
2019
Enhanced protection from fibrosis and inflammation in the combined absence of IL‐13 and IFN ‐γ
2016
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease
2019
Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential
2020
In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing
2015
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of Steven O’Reilly being referenced
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
2014
Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
2012
Tumor necrosis factor–costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts
2012
Differentiation Potential of CD14+ Monocytes into Myofibroblasts in Patients with Systemic Sclerosis
2012
Role of toll-like receptors in systemic sclerosis
2013
MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF-β Activated Kinase 1 Binding Protein 1, Implications for Systemic Sclerosis
2014
Targeting TLRs and the inflammasome in systemic sclerosis
2018
T cells in systemic sclerosis: a reappraisal
2012
Pound the alarm: danger signals in rheumatic diseases
2014
Emerging role of epigenetics in systemic sclerosis pathogenesis
2014
Epigenetics in fibrosis
2016
Role of interleukin‐13 in fibrosis, particularly systemic sclerosis
2013
Interleukin‐6: a new therapeutic target in systemic sclerosis?
2013
Histone Demethylation and Toll‐like Receptor 8–Dependent Cross‐Talk in Monocytes Promotes Transdifferentiation of Fibroblasts in Systemic Sclerosis Via Fra‐2
2016
Current frontiers in systemic sclerosis pathogenesis
2015
MicroRNAs in fibrosis: opportunities and challenges
2016
Innate immunity in systemic sclerosis pathogenesis
2013
Serum amyloid A induces interleukin‐6 in dermal fibroblasts via T oll‐like receptor 2, interleukin‐1 receptor‐associated kinase 4 and nuclear factor‐κB
2014
Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis
2020
Interleukin-6, its role in fibrosing conditions
2012